The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects
Chadi G. Abdallah(Baylor College of Medicine), Graeme F. Mason(Yale University), Christoph Juchem(Columbia University Irving Medical Center), Gerard Sanacora(Yale University), Douglas L. Rothman(Yale University), Brian Pittman(Yale University), Irina Esterlis(Yale University), Robin A. de Graaf(Yale University), Christopher L. Averill(United States Department of Veterans Affairs), John H. Krystal(Yale University), Henk M. De Feyter(Yale University), Golam M. I. Chowdhury(Yale University), Prerana Purohit(United States Department of Veterans Affairs), Lihong Jiang(Yale University), Lynnette A. Averill(Michael E. DeBakey VA Medical Center)
Cited by 226
Related Papers
How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k
The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome
|Proceedings of the National Academy of Sciences|2007|760
Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions
|World Psychiatry|2023|679
The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
|American Journal of Psychiatry|2017|669
A Functional Magnetic Resonance Imaging Study of Bipolar Disorder
|Archives of General Psychiatry|2003|475